A placebo controlled, randomized clinical trial of galcanezumab for vestibular migraine: The INVESTMENT study.
Saved in:
| Title: | A placebo controlled, randomized clinical trial of galcanezumab for vestibular migraine: The INVESTMENT study. |
|---|---|
| Authors: | Sharon JD; Department of Otolaryngology-Head and Neck Surgery, University of California, San Francisco, San Francisco, California, USA., Krauter R; Department of Otolaryngology-Head and Neck Surgery, University of California, San Francisco, San Francisco, California, USA., Chae R; Department of Otolaryngology-Head and Neck Surgery, University of California, San Francisco, San Francisco, California, USA., Gardi A; Department of Otolaryngology-Head and Neck Surgery, University of California, San Francisco, San Francisco, California, USA., Hum M; Department of Otolaryngology-Head and Neck Surgery, University of California, San Francisco, San Francisco, California, USA., Allen I; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California, USA., Levin M; Department of Neurology, University of California, San Francisco, San Francisco, California, USA. |
| Source: | Headache [Headache] 2024 Nov-Dec; Vol. 64 (10), pp. 1264-1272. Date of Electronic Publication: 2024 Sep 30. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 2985091R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1526-4610 (Electronic) Linking ISSN: 00178748 NLM ISO Abbreviation: Headache Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39344988 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: A placebo controlled, randomized clinical trial of galcanezumab for vestibular migraine: The INVESTMENT study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Sharon+JD%22">Sharon JD</searchLink>; Department of Otolaryngology-Head and Neck Surgery, University of California, San Francisco, San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Krauter+R%22">Krauter R</searchLink>; Department of Otolaryngology-Head and Neck Surgery, University of California, San Francisco, San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Chae+R%22">Chae R</searchLink>; Department of Otolaryngology-Head and Neck Surgery, University of California, San Francisco, San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Gardi+A%22">Gardi A</searchLink>; Department of Otolaryngology-Head and Neck Surgery, University of California, San Francisco, San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Hum+M%22">Hum M</searchLink>; Department of Otolaryngology-Head and Neck Surgery, University of California, San Francisco, San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Allen+I%22">Allen I</searchLink>; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Levin+M%22">Levin M</searchLink>; Department of Neurology, University of California, San Francisco, San Francisco, California, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%222985091R%22">Headache</searchLink> [Headache] 2024 Nov-Dec; Vol. 64 (10), pp. 1264-1272. <i>Date of Electronic Publication: </i>2024 Sep 30. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>2985091R <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1526-4610 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200178748%22">00178748 </searchLink><i>NLM ISO Abbreviation: </i>Headache <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39344988 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1111/head.14835 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1264 Titles: – TitleFull: A placebo controlled, randomized clinical trial of galcanezumab for vestibular migraine: The INVESTMENT study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Sharon JD – PersonEntity: Name: NameFull: Krauter R – PersonEntity: Name: NameFull: Chae R – PersonEntity: Name: NameFull: Gardi A – PersonEntity: Name: NameFull: Hum M – PersonEntity: Name: NameFull: Allen I – PersonEntity: Name: NameFull: Levin M IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 11 Text: 2024 Nov-Dec Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1526-4610 Numbering: – Type: volume Value: 64 – Type: issue Value: 10 Titles: – TitleFull: Headache Type: main |
| ResultId | 1 |